4/9/2020 EHS & MCS - Research and Treatment European Group - Electrosensible - Recherche et traitement

Welcome Diagnosis Protection Treatments Informations Research Contact

Accueil

Premiere of "Thank
You For Calling"
Premiere of the film « Thank You For Calling »
by Klaus Scheidsteger, played on the 15/12/16
in Lorient. Th film is about the American
scientist Georges Carlo and his discoveries on
the effects of mobile phones on health.

http://www.puremaison.fr/3647-
thickbox/thank-you-for-calling.jpg

Scientific Publication
First scientifc publication on objective
biological markers of

Welcome to the EHS & MCS website electrohypersensitivity and multiple

chemical sensitivity

Whether you are a doctor or a health care professional; whether you are sick, and/or you think you are
becoming intolerant to electromagnetic fields (EMF) or chemicals, this ehs-mcs website is intended for you. Reliable disease biomarkers characterizing
and identifying electrohypersensitivity and

It was created in the spirit of the Hippocratic oath and therefore is in strict compliance with Medical Ethics. It is multiple chemical sensitivity as two

mainly devoted to sick persons who need care and treatment according to the best medical and scientific etiopathogenic aspects of a unique

knowledge, in addition to a most accessible social framework. pathological disorder.

Note for people intolerant to electromagnetic fields.

To protect your health, for reading you are advised to print the website content. International
Declaration on
This website is the exclusive property of the Association for Research and Treatment of
electrohypersensitivity
Cancer (ARTAC). Its content in the form of printed documents cannot be shared without
ARTAC permission.
and multiple chemical
sensitivity
International Declaration on
electrohypersensitivity and multiple chemical
General background sensitivity

The content of this website is the result of several years of clinico-biologic research efforts to diagnose and
treat patients with self-reported electromagnetic hyper-sensitivity (EHS) and/or hyper-sensitivity to multiple
chemical products i.e. " Multiple chemical Sensitivity" (MCS). Research based on a series of more than 800
Press Conference
self-reported EHS and/or MCS patients was performed by the ARTAC research team coordinated by Dr
Dominique Belpomme: MD, MCS, full professor in medical oncology at the Paris University. These patient
See the press conference
investigations and follow-ups began in 2008 at the Georges Pompidou European Hospital, and from
September 2009 to today at the Alleray Labrouste private hospital, Paris 75015.

The research has been carried out at a French national level under the control of the ARTAC research
coordination team, and since 2011 at an international level, under the control of the Environment Research
Institute (ECERI) which ARTAC founded in Brussels (Belgium).

www.ehs-mcs.org/en/ 1/5
4/9/2020 EHS & MCS - Research and Treatment European Group - Electrosensible - Recherche et traitement
The data reported on this web site are from the international scientific literature and/or from the ARTAC and/or
ECERI’s experimental and clinical data, all resulting from a rigorous scientific research process and in
accordance with the principles of "evidence -based medicine." Therefore these data cannot be criticized other
than in the framework of the falsifiability principle, as proposed by the German scientific philosopher Karl
Popper and defended in France by a friend of Pr Belpomme, Jacques Monod, winner of the 1965 Medicine
Nobel Prize.

The exceptional gravity of the situation in terms of

public health The Fifth Paris Appeal
ARTAC and ECERI are non-profit private research organizations, independent of conflicting interests, primarily
Congress : 18th of
funded by donations and legacies from patients or their families, as well as sponsors who understood potential May, 2015
risks of excessive exposure to EMF and the inadequate market regulation of chemicals whose toxic effects are
insufficiently assessed. So ARTAC and ECERI scientists emphasize the extreme gravity of the public health IDIOPATHIC ENVIRONMENTAL
situation generated by environmental pollution, reflected in the increasing incidence of many chronic diseases INTOLERANCE: WHAT ROLE FOR
and some entirely new pathological disorders. Public health policies in the different countries around the world, ELECTROMAGNETIC FIELDS AND
particularly in the European Community, continue to minimize or deny the deleterious health effects of non- CHEMICALS?
ionizing radiation at various frequencies. The risks of chemicals still marketed without adequate toxicological
control, despite the basic reversal of burden of proof (“no toxicity data, no market”) in the new European A FOCUS ON
regulation REACH (Registration, Evaluation, Authorization of Chemicals). The Paris Appeal, initiated in 2004 at ELECTROHYPERSENSITIVITY (EHS) AND
UNESCO (Paris) by Professor Belpomme, contributed to REACH’s implementation, and ARTAC and ECERI MULTIPLE CHEMICAL SENSITIVITY (MCS)
continue to promote its goals at the scientific level.
was organised at the Royal Academy of
Medicine, Belgium on the 18th of May.

If you want to consult the program and the

abstracts of this congress, as well as the
program of the following Environmental
Medicine Course entitled "NEW SCIENCE
AND PRAXIS IN COMPLEX MULTISYSTEM
ILLNESSES", please click on the links below :

Sum-up of the 18th May congress

Abstracts of the 18th May 2015 Congress
Program 19th of May

Consultations
Whom and where can you consult ?

Towards environmental medicine

Towards environmental medicine For supporting the
research
Why has the EMF / chemical public health situation become so critical ?

Donate now
An key answer is that people claiming to be suffering from EHS and/or MCS represent only the tip of an
iceberg. We should indeed distinguish the three following clinic-biologic entities.

Pathologic intolerance is defined as the occurrence of clinical symptoms and biological dysfunctions in any
subject exposed to EMFs and/or chemicals without considering specifically susceptibility or hypersensitivity to
these agents. Any patient, potentially many, might display pathologic intolerance;

Susceptibility is a clinico-biologic condition related constitutionally to a particular genetic profile (or to

epigenetic acquired intracellular modifications as a consequence of environmental exposures). Due to the
continuing expansion of EMF and/or chemical exposures, such genetic/epigenetic susceptibility may affect an
increasing number of people. Scientific bibliography
Hypersensitivity is a specific condition characterized by susceptible patients becoming clinically and
biologically intolerant to weaker intensities of EMFs and/ or low concentrations of chemicals than they may
have originally been exposed to. Less numerous than intolerant people, these EHS and MCS patients may
even so represent the tip of the iceberg. We must consider the hypersensitivity syndrome as an indicator of a
much larger public health problem: thelarge numbers of people who have not necessarily become
hypersensitive who may in fact be intolerant to these agents; and that their ubiquitous prolonged exposures

www.ehs-mcs.org/en/ 2/5
4/9/2020 EHS & MCS - Research and Treatment European Group - Electrosensible - Recherche et traitement
may generate a number of chronic organic disorders or diseases; which unfortunately medicine still considers
idiopathic, i.e. without any recognized cause. It is possible that such widespread intolerance phenomena,
especially when associated with progressive organic damage, may account for much of the apparent increased
incidence (few baseline measures exist) of widesprad pathological conditions, such as migraine, heart rhythm
disorders, chemical-induced asthma and other obstructive bronchial diseases, skin diseases, chronic
rheumatisms and many other autoimmune diseases, degenerative neuropathies (including Alzheimer's,
Parkinson's, multiple sclerosis and even amyotrophic lateral sclerosis), autism in children, and even several
types of cancers and leukemias. The incidence of non-infectious chronic diseases has been growing strongly
for decades (when a baseline can be established), while modern medicine still considers them to be largely
idiopathic.

Taking into account worldwide scientific research and the results of our own research highlighting the causal
role of the environment in the emergence of some of these pathological disorders or diseases, we believe that
the diagnostic and therapeutic management of such patients must occur within the framework of a new
extremely multi-disciplinary form of medical practice designated “environmental medicine”. ARTAC has
implemented environmental medicine in France and now, thanks to ECERI in Europe, with the objective to
diagnose and treat patients using the best evidence-based techniques, supplying in France highly specialized
medical consultations.

Scientific publications
Several scientific papers arising from ARTAC’s research have already been published. Others are in press and
more will be submitted to top journals, pending financial support which neither ARTAC nor ECERI currently
have sufficiently. Nevertheless, our research and dissemination efforts continue relentlessly, as ARTAC has
extensive clinical and biological experience in its field. ARTAC’s series of clinically examined and biologically
investigated and treated patients with EHS and/or MCS is probably one of the largest worldwide. It is
noteworthy that ARTAC discovered new biological tests and innovative treatments of great use to highly
integrated practice of environmental medicine.

The need for scientific independence.

Another key asset for ARTAC and ECERI’s research success in the field of EHS and MCS diagnosis and
treatment is their allegiance to objectivity in science, independent of any political pressures or administrative
ideologies and private interests (profit over knowledge) of electromagnetic and chemical industries. The
recognized scientific expertise and quality of research work of ARTAC and ECERI in the field of EHS and MCS
derive from their independence when performing scientific research and reaching new scientific knowledge;
from their internationally recognized competence in a field as complex as cancer; and from their public
expressions concerning the social implications of scientific results. ARTAC and ECERI’s researchers are
indeed not systematically opposed to industrial technological innovations, when these are useful and honestly
beneficial to populations. But ARTAC’s priority is the care of patients in the best medico-social conditions.
Therefore health policy is paramount, and ARTAC and ECERI promote exposure restrictions, rather than the
current economic excess and environmental spill-over known to be driven mainly by private profit-seeking.

Un autre atout primordial concernant les recherches de l'ARTAC et de l’ECERI est leur totale indépendance
scientifique vis-à-vis des pouvoirs administratifs et politiques quels qu’ils soient et des lobbies en provenance

www.ehs-mcs.org/en/ 3/5
4/9/2020 EHS & MCS - Research and Treatment European Group - Electrosensible - Recherche et traitement
des opérateurs et industriels impliqués dans les technologies sans fils ou la chimie. Ce qui assure la véracité
scientifique des travaux de l’ARTAC et/ou de l’ECERI est justement leur indépendance dans le choix des
thématiques de recherche envisagées, leur compétence internationalement reconnue dans un domaine aussi
complexe qu’est le cancer et leur liberté d'expression au plan national et international vis-à-vis du grand public,
une fois les travaux scientifiques réalisés et éventuellement publiés.

Il ne s'agit pas ici de s'opposer systématiquement aux innovations technologiques de l'industrie lorsque celles-
ci sont utiles et bénéfiques pour les populations, mais d’abord et avant tout au plan médical, de prendre en
charges les malades victimes de ces affections ou maladies, dans des conditions médico-sociales les plus
satisfaisantes possibles, et au plan de la santé publique d'instituer et de promouvoir auprès des décideurs
politiques des limites sanitaires raisonnables, face aux excès économiques actuels dont on sait qu’ils sont
guidés par une logique principalement, si ce n’est exclusivement, financière.

Menu
This website will be uploaded and updated with scientific and medical (diagnostic and therapeutic) research. It
includes the following topics:

Diagnosis

1) How can we define intolerance and susceptibility and distinguish them from hypersensitivity to
electromagnetic fields and/or chemicals,

2) Clinical and biological description of the electromagnetic field intolerance syndrome (EMFIS),

3) What evidence do we have of the causal role of EMF in the development of EMFIS?

4) Do patients claiming to be EHS bear psychiatry diseases?

5) What are the diagnostic criteria of EMFIS ?

6) Clinical and biological description of the multiple chemical sensitivity syndrome (MCS),

7) Diagnostic criteria of MCS,

8) Differential diagnosis,

9) Clinical forms of EMF and/or chemical intolerance,

10) Hypothesis about common patho-physiological mechanisms accounting for EHS and/or MCS genesis,

11) Familial forms of EHS and MCS,

12) A particular clinical form of MCS: cutaneous intolerance to synthetic fibers.

Protection

1) Understanding of what are EMFs and their health effects

2) How can we avoid EMF intolerance,

3) How can we protect ourselves when suffering from EHS ?,

4) Understanding chemical pollution and practical advice to protect ourselves when suffering MCS,

5) Physical barriers and/or societal prejudices: What can we do ?

Treatments

1) What treatments are possible for patients with EHS and/or MCS ? ARTAC and ECERI therapeutic clinical
trials,

2) Whom and where can you consult ?

3) Removal of mercury amalgams: how and whom can you consult ?

4) Poisoning by heavy metals : what can be done ?

www.ehs-mcs.org/en/ 4/5
4/9/2020 EHS & MCS - Research and Treatment European Group - Electrosensible - Recherche et traitement
5) What are food allergies and food intolerances ? What can be done in case of allergy or food intolerance ?

Information

1) Patient assistance. How can you organize to act effectively?

2) In case of serious health and social problems, who can be contacted?

3) Some useful contacts for protecting oneself

4) Where do we stand regarding the recognition of EHS and MCS by governmental bodies as WHO and the
different Member States of the European Union?

Scientific research

1) Learn more about ARTAC and ECERI,

2) ARTAC and ECERI’s current scientific studies,

3) Help fund research: why and how can you help ARTAC or ECERI to improve EHS and MCS diagnosis and
treatment,

References

Haut de page

Website map - ARTAC - 57/59 rue de la Convention 75015 PARIS FRANCE - Tél. : 00 33 (0)1 45 78 53 53 - Fax : 00 33 (0)1 45 78 53 50 - Email : artac.cerc@gmail.com - Version Française

www.ehs-mcs.org/en/ 5/5